DGX vs RCAT · P/E 22, rev $5.94B vs rev $35.7M
Quest Diagnostics Incorporated (DGX) versus Red Cat Holdings Inc (RCAT) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Red Cat Holdings Inc (RCAT) is a aerospace & defense company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported RCAT revenue for 2026-06-30 was $35.7M. Net income was -$61.8M. RCAT currently screens at market cap $1.70B.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. RCAT currently screens at market cap $1.70B.
Not investment advice. Open the DGX and RCAT stock pages for the full models.
Not investment advice.